These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 38117433)

  • 1. Mesenchymal stem cell therapy for COVID-19 infection.
    Alavi-Dana SMM; Gholami Y; Meghdadi M; Fadaei MS; Askari VR
    Inflammopharmacology; 2024 Feb; 32(1):319-334. PubMed ID: 38117433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical role of mesenchymal stromal/stem cell therapy in COVID-19 patients: An updated review.
    Ebrahimi M; Rad MTS; Zebardast A; Ayyasi M; Goodarzi G; Tehrani SS
    Cell Biochem Funct; 2021 Dec; 39(8):945-954. PubMed ID: 34545605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential.
    Xiong J; Bao L; Qi H; Feng Z; Shi Y
    Curr Stem Cell Res Ther; 2021; 16(2):105-108. PubMed ID: 32479246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19.
    Cai Q; Yin F; Hao L; Jiang W
    Stem Cells Dev; 2021 May; 30(9):459-472. PubMed ID: 33715385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
    Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
    Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells.
    Wang L; Li Y; Xu M; Deng Z; Zhao Y; Yang M; Liu Y; Yuan R; Sun Y; Zhang H; Wang H; Qian Z; Kang H
    Front Immunol; 2021; 12():726909. PubMed ID: 34394132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Therapeutic Role of Mesenchymal-Derived Stem Cells as an Alternative Therapy to Combat COVID-19 through Cytokines Storm.
    Upadhyay TK; Trivedi R; Khan F; Pandey P; Sharangi AB; Goel H; Saeed M; Park MN; Kim B
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm.
    Song N; Wakimoto H; Rossignoli F; Bhere D; Ciccocioppo R; Chen KS; Khalsa JK; Mastrolia I; Samarelli AV; Dominici M; Shah K
    Stem Cells; 2021 Jun; 39(6):707-722. PubMed ID: 33586320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope.
    Pal D; Goyal J; Sharma U; Sharma A; Prashar S; Rathi G; Sharma B; Kumar U
    Life Sci; 2021 Nov; 284():119901. PubMed ID: 34453941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients.
    Heidari F; Heidari R; Sabet MN; Hamidieh AA; Saltanatpour Z
    Curr Stem Cell Res Ther; 2024; 19(5):644-652. PubMed ID: 37073149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
    Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
    Front Immunol; 2021; 12():738697. PubMed ID: 34659231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis of mesenchymal stromal/stem cells as strategical means for the treatment of COVID-19.
    Taufiq H; Shaik Fakiruddin K; Muzaffar U; Lim MN; Rusli S; Kamaluddin NR; Esa E; Abdullah S
    Ther Adv Respir Dis; 2023; 17():17534666231158276. PubMed ID: 37128999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
    Sadeghi S; Soudi S; Shafiee A; Hashemi SM
    Life Sci; 2020 Dec; 262():118493. PubMed ID: 32979360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Hematologic Parameters in Patients with COVID-19 Following Mesenchymal Stem Cell Therapy.
    Bakhshi H; Soleimani M; Soufizomorrod M; Kooshkaki O
    DNA Cell Biol; 2022 Aug; 41(8):768-777. PubMed ID: 35914059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study.
    Grumet M; Sherman J; Dorf BS
    Stem Cells Transl Med; 2022 Nov; 11(11):1103-1112. PubMed ID: 36181766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines.
    Tufan AC
    Curr Stem Cell Res Ther; 2021; 16(4):465-480. PubMed ID: 33238848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment.
    Huang Y; Li X; Yang L
    Stem Cell Res Ther; 2022 Aug; 13(1):410. PubMed ID: 35962458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretome of Mesenchymal Bone Marrow Stem Cells: Is It Immunosuppressive or Proinflammatory?
    Kiselevskii MV; Vlasenko RY; Stepanyan NG; Shubina IZ; Sitdikova SM; Kirgizov KI; Varfolomeeva SR
    Bull Exp Biol Med; 2021 Dec; 172(2):250-253. PubMed ID: 34855084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?
    Askenase PW
    J Extracell Vesicles; 2020 Oct; 10(1):e12004. PubMed ID: 33304473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.